[Augmentation of the action of antidiabetic pharmaceutic products due to the use of monoamine oxidase inhibitors and beta blockaders].
作者信息
Parodi F A
出版信息
Journ Annu Diabetol Hotel Dieu. 1969;10:21-8.
PMID:5376979
Abstract
摘要
相似文献
1
[Augmentation of the action of antidiabetic pharmaceutic products due to the use of monoamine oxidase inhibitors and beta blockaders].
Journ Annu Diabetol Hotel Dieu. 1969;10:21-8.
2
The action of mebanazine, a mono amine oxidase inhibitor antidepressant drug in diabetes. II.单胺氧化酶抑制剂抗抑郁药美巴嗪在糖尿病中的作用。II.
Int J Neuropsychiatry. 1966 Aug;2(4):342-5.
3
[Development of pharmacologic criteria for development of antianginal medications].
Brux Med. 1969 Sep;49(9):543-60.
4
Modification of insulin and sulfonylurea hypoglycemia by monoamine-oxidase inhibitor drugs.
Diabetes. 1967 Apr;16(4):272-4. doi: 10.2337/diab.16.4.272.
5
[Value of the use of monoamine oxidase inhibitors in the treatment of diabetes mellitus].[单胺氧化酶抑制剂在糖尿病治疗中的应用价值]
Med Interna (Bucur). 1967 Apr;19(4):457-60.
6
[Drug and therapeutic interactions in diabetes mellitus].[糖尿病中的药物与治疗相互作用]
Sem Hop Ther. 1977 Apr;53(4):231-2.
7
[Value of an antiadrenal drug (O.P.'D.D.D.) in treatment of various diabetic states].[一种抗肾上腺药物（邻对滴滴滴）在治疗各种糖尿病状态中的价值]
Diabete. 1968 Jul-Sep;16(3):220-9.
8
[New data on the drug therapy of angina pectoris].
Z Gesamte Inn Med. 1966 Nov 1;21(21):641-9.
9
[Drug interactions with vitamin K antagonists].[维生素K拮抗剂的药物相互作用]
Pathol Biol (Paris). 1973 Jun;21(6):639-46.
10
[Drug therapy of common angina pectoris].
Tunis Med. 1971 Sep-Oct;49(5):309-12.
Zotero 插件